Takeda Pharmaceutical Co Ltd 4502.T-JP:Tokyo Stock Exchange

*Data is delayed | JPY
Last | 06/14/21 JST
3,730.00quote price arrow down-49.00 (-1.30%)
Volume
2,180,300
52 week range
3,239.00 - 4,365.00

...

Loading . . .
  • Open3,777.00
  • Day High3,783.00
  • Day Low3,725.00
  • Prev Close3,779.00
  • 52 Week High4,365.00
  • 52 Week High Date03/22/21
  • 52 Week Low3,239.00
  • 52 Week Low Date10/30/20

Key Stats

  • Market Cap53,821.25M
  • Shares Out1,563.36M
  • 10 Day Average Volume5.5M
  • Dividend180.00
  • Dividend Yield4.83%
  • Beta1.07
  • YTD % Change-0.67

KEY STATS

  • Open3,777.00
  • Day High3,783.00
  • Day Low3,725.00
  • Prev Close3,779.00
  • 52 Week High4,365.00
  • 52 Week High Date03/22/21
  • 52 Week Low3,239.00
  • 52 Week Low Date10/30/20
  • Market Cap53,821.25M
  • Shares Out1,563.36M
  • 10 Day Average Volume5.5M
  • Dividend180.00
  • Dividend Yield4.83%
  • Beta1.07
  • YTD % Change-0.67

RATIOS/PROFITABILITY

  • EPS (TTM)159.70
  • P/E (TTM)23.36
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date03/30/2021
  • Div Amount90.00
  • Split Date-
  • Split Factor-

Latest On Takeda Pharmaceutical Co Ltd

There is no recent news for this security.

Profile

MORE
Takeda Pharmaceutical Company Limited is a Japan-based company mainly engaged in the pharmaceutical business. The Company is engaged in the research, development, manufacture and sale of pharmaceutical products, General medical products, quasi drugs and healthcare products in Japan and overseas. The Company's research and development functions are concentrated in four areas of oncology (cancer), digestive system diseases, rare diseases and neurology (neuropsychiatric...
Masahiro Sakane
Chairman
Christophe Weber
President
Constantine Saroukos
Chief Financial Officer
Address
4F, 2-1-1, Nihombashihon-cho
Chuo-ku, TKY
103-8668
Japan